S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end

Hepion Pharmaceuticals (HEPA) News Today

$2.01
-0.10 (-4.74%)
(As of 04/19/2024 ET)
SourceHeadline
finanznachrichten.de logoHepion Pharmaceuticals, Inc.: Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b 'ASCEND-NASH' Trial
finanznachrichten.de - April 20 at 7:53 AM
marketwatch.com logoHepion Pharma to Wind-Down Phase 2b Ascend-NASH Trial, Cites Resource Constraints
marketwatch.com - April 19 at 8:33 PM
marketwatch.com logoHepion Pharma Shares Plunge 31% After Disclosing Plans to Wind Down Trial
marketwatch.com - April 19 at 8:33 PM
finance.yahoo.com logoHepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
finance.yahoo.com - April 19 at 8:33 PM
marketbeat.com logo
marketbeat.com - April 19 at 4:32 PM
globenewswire.com logoHepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH' Trial
globenewswire.com - April 19 at 4:30 PM
msn.com logoHEPA Stock Earnings: Hepion Pharmaceuticals Beats EPS for Q4 2023
msn.com - April 17 at 12:39 AM
MarketBeat logoShort Interest in Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) Expands By 11.0%
americanbankingnews.com - April 15 at 6:42 AM
morningstar.com logoHepion Pharmaceuticals Inc HEPA
morningstar.com - April 14 at 6:46 PM
investing.com logoHepion Pharmaceuticals Inc (HEPA)
investing.com - March 24 at 2:04 AM
globenewswire.com logoHepion Pharmaceuticals Strengthens Board of Directors with Appointment of Michael Purcell
globenewswire.com - March 6 at 8:30 AM
finance.yahoo.com logoHepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
finance.yahoo.com - February 16 at 10:34 AM
globenewswire.com logoHepion Pharmaceuticals Announces Exercise of Warrants for Approximately $2.0 Million Aggregate Gross Proceeds
globenewswire.com - February 16 at 8:00 AM
finance.yahoo.com logoHepion Pharmaceuticals to Present at NASH-TAG 2024
finance.yahoo.com - January 3 at 6:40 PM
finanznachrichten.de logoHepion Pharmaceuticals, Inc.: Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
finanznachrichten.de - December 7 at 2:59 PM
realmoney.thestreet.com logoHepion Pharmaceuticals downgraded to Hold from Buy at Brookline
realmoney.thestreet.com - December 7 at 2:59 PM
marketwatch.com logoHepion Sets Restructuring; To Explore Strategic Options
marketwatch.com - December 7 at 9:59 AM
finance.yahoo.com logoHepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
finance.yahoo.com - December 7 at 9:59 AM
marketbeat.com logo
marketbeat.com - December 7 at 7:58 AM
finance.yahoo.com logoHepion Pharmaceuticals to Present at the 7th Obesity & NASH Drug Development Summit
finance.yahoo.com - November 28 at 4:19 PM
msn.com logoHepion Pharmaceuticals says Wijngaard buys 5K shares in co
msn.com - November 28 at 3:41 PM
finance.yahoo.com logoHepion Pharmaceuticals Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment in 17-week Phase 2 Study of Advanced (F3) MASH Liver Disease
finance.yahoo.com - November 13 at 6:24 PM
benzinga.com logoHepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 'ALTITUDE-NASH' Liver Function Trial of Rencofilstat
benzinga.com - November 10 at 1:42 PM
finance.yahoo.com logoHepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat
finance.yahoo.com - November 10 at 9:22 AM
money.usnews.com logoGSK Signs $1 Billion Deal for Exclusive License to J&J's Hepatitis B Therapy
money.usnews.com - October 31 at 9:19 AM
finanznachrichten.de logoHepion Pharmaceuticals, Inc.: Hepion Pharmaceuticals' Rencofilstat Demonstrates Anti-Cancer Activity in Hepatitis C-Associated Cancer Model
finanznachrichten.de - October 25 at 9:35 AM
finance.yahoo.com logoHepion Pharmaceuticals’ Rencofilstat Demonstrates Anti-Cancer Activity in Hepatitis C-Associated Cancer Model
finance.yahoo.com - October 25 at 9:35 AM
marketbeat.com logo
marketbeat.com - October 13 at 2:52 PM
msn.com logoHepion to sell $5M in shares through registered direct offering
msn.com - September 29 at 1:23 PM
finance.yahoo.com logoHepion Pharmaceuticals Announces $5.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market under Nasdaq Rules
finance.yahoo.com - September 29 at 8:23 AM
finance.yahoo.com logoHepion Pharmaceuticals to Participate in 2023 Cantor Global Healthcare Conference
finance.yahoo.com - September 21 at 5:56 PM
finance.yahoo.com logoNew Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals’ Rencofilstat in Cancer Screening Program
finance.yahoo.com - September 21 at 9:54 AM
finance.yahoo.com logoHere's Why Hepion Pharmaceuticals (NASDAQ:HEPA) Must Use Its Cash Wisely
finance.yahoo.com - September 19 at 12:52 PM
finance.yahoo.com logoHepion Pharmaceuticals Discovers Novel Rencofilstat Action in Liver Cancer
finance.yahoo.com - September 19 at 9:55 AM
finance.yahoo.com logoInsider Buying: Robert Foster Acquires 1,600 Shares of Hepion Pharmaceuticals Inc
finance.yahoo.com - September 18 at 11:28 AM
finance.yahoo.com logoRencofilstat Produces Positive Outcomes in Translational Study on Idiopathic Pulmonary Fibrosis
finance.yahoo.com - September 14 at 9:29 AM
msn.com logoHepion Pharmaceuticals' CMO Todd Hobbs resigns
msn.com - September 7 at 5:27 PM
finance.yahoo.com logoHepion Pharmaceuticals Announces Management Changes
finance.yahoo.com - September 6 at 5:37 PM
finance.yahoo.com logoWall Street Analysts Think Hepion Pharmaceuticals, Inc. (HEPA) Could Surge 674.09%: Read This Before Placing a Bet
finance.yahoo.com - September 6 at 4:30 PM
finance.yahoo.com logoHEPA - Hepion Pharmaceuticals, Inc.
finance.yahoo.com - August 16 at 3:18 AM
seekingalpha.com logoHEPA Hepion Pharmaceuticals, Inc.
seekingalpha.com - July 25 at 1:45 AM
finance.yahoo.com logoHepion Pharmaceuticals to Present Two Posters at EASL International Liver Congress™ 2023
finance.yahoo.com - June 15 at 6:35 PM
finance.yahoo.com logoHepion Pharmaceuticals to Highlight AI-POWR™ at the 2023 CSPS Annual Symposium: The Next Frontiers in Pharmaceutical Sciences
finance.yahoo.com - May 24 at 5:08 PM
finance.yahoo.com logoHere's Why Hepion Pharma (HEPA) is Up More Than 80% in Two Days
finance.yahoo.com - May 24 at 2:12 PM
msn.com logoWhy Hepion Pharmaceuticals Stock Is Soaring Monday
msn.com - May 22 at 10:54 AM
msn.com logoHepion Skyrockets on Promising Phase 2 Data in NASH
msn.com - May 22 at 10:54 AM
reuters.com logoHepion NASH drug meets main goal in mid-stage trial
reuters.com - May 22 at 8:35 AM
marketwatch.com logoHepion Pharmaceuticals Shares Soar Premarket Ahead of NASH Study Update >HEPA
marketwatch.com - May 22 at 8:35 AM
markets.businessinsider.com logoHepion Pharma: Phase 2 ALTITUDE-NASH Trial With Rencofilstat Meets Efficacy, Safety Endpoints
markets.businessinsider.com - May 22 at 8:35 AM
marketwatch.com logoHepion Shares Continue to Rise as NASH Study Hits Key Endpoints >HEPA
marketwatch.com - May 22 at 8:35 AM
Get Hepion Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for HEPA and its competitors with MarketBeat's FREE daily newsletter.

Bitcoin Rockets To Record High But Buy THIS Instead (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

HEPA Media Mentions By Week

HEPA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

HEPA
News Sentiment

0.34

0.51

Average
Medical
News Sentiment

HEPA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

HEPA Articles
This Week

10

1

HEPA Articles
Average Week

Get Hepion Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for HEPA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:HEPA) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners